Want to join the conversation?
Medical testing and diagnostic products maker $TECH reported a drop in 4Q16 earnings due to negative impact by mix of lower-margin acquisitions, investments and higher stock based compensation. Net income slid to $25.63MM or $0.69 per share from $26.33MM or $0.71 per share in 4Q15. Net sales grew 15% to $134.76MM. Adjusted EPS rose 2% to $0.92.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?